ByTrending Posts
Did Oncology Approvals in 2025 Reshape the Competitive…
Global – December 2025 — The oncology sector reached a strategic inflection point in 2025, as a surge…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical…
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
Phase 3 Clinical Trials of Setrusumab in Osteogenesis…
London & Novato, Calif. — December 2025 Mereo BioPharma Group plc (NASDAQ: MREO) and Ultragenyx Pharmaceutical Inc. (NASDAQ:…
The Best Feeling Is When Our Drugs Succeed”:…
London | December 2025 GlaxoSmithKline (GSK) today highlighted a defining reflection from its outgoing Chief Executive Officer, Dame…
Neuroscience Biopharma in Transformation: Pipeline and Commercial Dynamics…
Washington, D.C. — The neuroscience segment is undergoing a significant strategic transformation, driven by breakthroughs in neurodegenerative, psychiatric,…
How Will New U.S. Drug Pricing Policies Reshape…
Washington, D.C. — December 29, 2025 — Recent changes in U.S. drug pricing policies are fundamentally reshaping the…
How Did Merck’s 2025 Deals Strengthen Its Pipeline…
In 2025, Merck pursued a series of high-impact collaborations, acquisitions, and licensing agreements to expand its portfolio, enhance…
Did Merck’s 2025 Strategies, Deals, and Pipeline Strength…
Merck concluded 2025 with a strong performance across its pharmaceuticals, vaccines, and oncology segments, demonstrating resilience, strategic focus,…
Did AstraZeneca’s 2025 Deals Lay the Groundwork for…
In 2025, AstraZeneca executed a series of strategic collaborations, partnerships, and selective acquisitions designed to strengthen its pipeline,…
Trending Posts
Latest Stories
Roche Reports Full-Year 2025 Results and Provides Strategic Portfolio Insights
Roche today announced its full-year 2025 performance and outlined its strategic positioning across key therapeutic…
Top 10 Pharma Brands of 2025 — Sales Performance, Company Strategy & Market Outlook
The pharmaceutical market in 2025 was defined by high-value specialty brands delivering breakthrough outcomes in…
Big Pharma Accelerates Shift to Off-the-Shelf Cell Therapy with Strategic Acquisitions
The global biopharmaceutical industry is entering a new phase in cell therapy innovation, marked by…
Drugmakers Use AI to Speed Trials and Regulatory Filings
Pharmaceutical companies are increasingly using artificial intelligence to streamline clinical trials and regulatory filings. While…
Gallery
